Author Archive for: admin Z.9

About admin Z.9

This author has not written his bio yet.
But we are proud to say that admin Z.9 contributed 1143 entries already.

Entries by admin Z.9

Article of the Month: The Melbourne Consensus Statement

Every month the Editor-in-Chief selects an Article of the Month from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the […]

Video: Why the Melbourne Statement?

The Melbourne Consensus Statement on the early detection of prostate cancer Declan G. Murphy1,2,3, Thomas Ahlering4, William J. Catalona5, Helen Crowe2,3, Jane Crowe3, Noel Clarke10, Matthew Cooperberg6, David Gillatt11, Martin Gleave12, Stacy Loeb7, Monique Roobol14, Oliver Sartor8, Tom Pickles13, Addie Wootten3, Patrick C. Walsh9 and Anthony J. Costello2,3 1Peter MacCallum Cancer Centre, 2Royal Melbourne Hospital, University of Melbourne, […]

What’s the diagnosis?

Test yourself against our experts with our weekly quiz. You can type your answers here if you want to compare with our answers, or just click the ‘submit’ button below. Image from Emara AM et al. BJU Int 2014; 113: 92–99. doi: 10.1111/bju.12252 No such quiz/survey/poll

Article of the week: Obese patients should not be denied RARP

Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the […]

What’s the diagnosis?

Test yourself against our experts with our weekly quiz. You can type your answers here if you want to compare with our answers, or just click the ‘submit’ button below. No such quiz/survey/poll

Video: PCa in older men, is it really low-grade disease?

  Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer Ayal A. Aizer*, Ming-Hui Chen‡, Jona Hattangadi* and Anthony V. D’Amico† *Harvard Radiation Oncology Program, Boston, MA, †Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, MA, and, ‡Department of Statistics, University of Connecticut, Storrs, CT, […]

What’s the diagnosis?

Test yourself against our experts with our weekly quiz. You can type your answers here if you want to compare with our answers, or just click the ‘submit’ button below. Image from O’Brien et al. BJU Int 2013; 112: 1096–1104. doi: 10.1111/bju.12355 No such quiz/survey/poll

Article of the week: SEER shows no benefit from LND in RCC

Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the […]

Video: Survival for RCC and nodal metastases

Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data Maxine Sun*, Quoc-Dien Trinh*‡, Marco Bianchi*¶, Jens Hansen*††, Firas Abdollah¶, Zhe Tian*, Shahrokh F. Shariat§, Francesco Montorsi¶, Paul Perrotte† and Pierre I. Karakiewicz*† *Cancer Prognostics and Health Outcomes Unit, †Department of Urology, University of Montreal […]

© 2024 BJU International. All Rights Reserved.